What histopathologic features have been reported in liver biopsies after mRNA COVID-19 vaccination?
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Liver biopsies reported after SARS‑CoV‑2 mRNA vaccination most often show an active, inflammatory hepatitis pattern—frequently described as moderate to severe lobular/portal inflammation with features overlapping autoimmune hepatitis (AIH), including interface hepatitis, portal inflammation, lymphoplasmacytic infiltrates, and lobular inflammation; one case series found moderate-to-severe active hepatitis in 9 of 13 biopsies (69%) [1] [2]. Other reported histologic patterns include resolving hepatitis, cholestatic hepatitic injury, bile duct injury, centrilobular necrosis, and hepatocellular cholestasis; many reports note positive autoantibodies or elevated IgG alongside biopsy findings [1] [3] [4] [5] [6].
1. Dominant pattern: “active hepatitis” with autoimmune-like features
Multiple case series and reviews converge on active hepatitis as the common histologic picture after COVID‑19 vaccination, often with panlobular or lobular inflammation and portal/interface activity resembling AIH. A 2025 pathology series of 13 biopsies reported moderate to severe active hepatitis in 9 of 13 samples (69%) [1] [2]. Larger international cohorts also describe frequent lobular inflammation typical of recent injury and autoantibodies commonly positive, reinforcing the “autoimmune‑like” phenotype [3] [6].
2. Classical AIH histology appears repeatedly but not uniformly
Features typical of autoimmune hepatitis recur across reports: interface (portal) hepatitis, portal inflammation, rosette formation, and lymphoplasmacytic infiltrates with plasma cells and eosinophils appear in case reports and systematic reviews [7] [8] [5]. Systematic reviews and pooled series found many biopsy results consistent with AIH by diagnostic criteria, yet authors also caution that not all cases display the full serologic or histologic AIH signature [9] [6].
3. Heterogeneous patterns: cholestasis, bile‑duct injury, centrilobular necrosis
Not all post‑vaccine biopsies mimic AIH. Single‑case reports and small series document cholestatic hepatitic injury, bile duct injury, hepatocellular cholestasis with ceroid‑laden Kupffer cells, and centrilobular necrosis—patterns more suggestive of idiosyncratic drug‑induced liver injury (DILI) or mixed injury [1] [4] [8] [5]. The 13‑biopsy series explicitly identified one each of resolving hepatitis, cholestatic hepatitic injury, and bile duct injury [1].
4. Immune markers and molecular signals: serology, IgG, mRNA detection
Many reports pair histology with positive autoantibodies (ANA, SMA) and elevated IgG, supporting an immune‑mediated mechanism in a substantial subset [6] [3]. One study reported in‑situ detection of vaccine mRNA in hepatocyte cytoplasm and CD8‑predominant infiltrates with spike‑specific clones in a biopsy, suggesting possible local immune activation—though such molecular findings are limited to individual reports [10] [11].
5. Clinical course, treatment response and diagnostic caution
Most patients with biopsy‑proven injury recovered spontaneously or after corticosteroids; one series noted recovery in all but one patient who progressed to autoimmune hepatitis [1] [6]. Authors repeatedly warn that biopsy findings overlap with idiopathic AIH and with DILI, so biopsy alone cannot prove causality and must be interpreted with clinical, serologic, and temporal context [8] [9].
6. Scale and selection bias: what the literature can and cannot claim
Available series are small, retrospective, and concentrated in symptomatic patients who underwent biopsy; systematic reviews include limited case numbers and heterogeneous vaccine exposures [9] [3]. Therefore, reported histologic patterns represent a biased sample of people with clinically significant injury, not population‑level incidence—reviews and cohorts acknowledge that vaccine‑associated liver injury is rare and that causality is not definitively established in most reports [9] [8].
7. Competing interpretations and open questions
Pathologists and hepatologists interpret the same features differently: some frame findings as vaccine‑triggered AIH‑like syndromes, others emphasize that acute liver injury of many causes can mimic AIH histologically and that confounders (drugs, preexisting autoimmunity) are common in case series [12] [5] [13]. Molecular mimicry and lipid‑nanoparticle‑driven inflammation are proposed mechanisms, but large‑scale mechanistic confirmation is not yet available in the cited literature [10] [12]. Available sources do not mention definitive population rates or randomized evidence proving causation.
Limitations: this analysis uses only the supplied reports and reviews; the published data are small and observational, with acknowledged selection bias [9] [3]. Clinicians should integrate biopsy findings with clinical history, serology, timing after vaccination, and alternative causes before labeling injury as vaccine‑related [8] [6].